Pulling SEC filings + quote and writing the call…

Everforth Inc
Next earnings Jul 21, 2026 (after close) · consensus $0.83 EPS, $1.01B rev
Last earnings -0.3% on 2026-04-22
Cheap optical 6.8x P/E masks a 5-year earnings slide, DOGE-driven Federal headwinds, and a levered balance sheet — but Consulting growth + buybacks earn a hold.
Revenue $3.98B · FY2025
Fundamentals and price both look middling — no strong edge either way.
EFOR (operating as ASGN per the 10-K) is a two-segment IT services business where the bull case — Commercial Consulting revenue up 14.4% to $1.29B — is being offset by a 13.8% collapse in Assignment staffing revenue ($1.50B) and a 3.3% decline in the Federal Government segment tied explicitly in the MD&A to 'the loss of certain contracts as a result of initiatives associated with DOGE.' Total revenue fell 2.9% to $3.98B, marking the fourth consecutive annual decline from the $4.58B FY2022 peak, and net income has now compressed from $410M (FY2021) to $114M (FY2025) — a 72% cumulative drop. Diluted EPS of $2.60 is down 32% YoY.
Margin quality is deteriorating where it matters: SG&A rose to 21.5% of revenue from 20.0%, eating the entire 30bp gross-margin gain in Commercial. Management flagged $26.5M of acquisition/integration/strategic charges (including $5.2M in 'strategic workforce optimization') plus a $4.4M software write-off — signals of a business actively restructuring. Federal gross margin dropped 70bp on low-margin software mix and DOGE-related contract losses. Operating margin compressed to 5.8% and ROE is a thin 6.3%. Meanwhile long-term debt grew 13.1% to $1.17B against $161M cash (down 21.4%), and weighted-average borrowings rose to $1.21B at 5.6% — the company is funding TopBloc-related goodwill and $170M of buybacks with debt, not cash generation (OCF down 18% to $328M).
Is EFOR a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $4.01B | $4.58B | $4.45B | $4.10B | $3.98B |
| Gross profit | $1.14B | $1.37B | $1.28B | $1.18B | $1.15B |
| Operating income | $351M | $410M | $364M | $304M | $230M |
| Net income | $410M | $268M | $219M | $175M | $114M |
| Diluted EPS | $7.66 | $5.23 | $4.50 | $3.83 | $2.60 |
| Net margin | 10.2% | 5.9% | 4.9% | 4.3% | 2.9% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results disclosed; routine director/auditor ratification outcome.
Q1'26 10-Q details continued margin compression; SG&A rising as % of revenue.
2026 proxy: routine board/auditor/comp items; no major governance changes.
Amended bylaws/charter; governance housekeeping with no direct economic impact.
Q1'26 results released amid ongoing revenue softness and DOGE-driven federal pressure.
FY25 10-K: rev -2.9%, NI -35%, debt +13%, buybacks halved; cash -21% to $161M.
Q4'25 results: revenue -2.9% FY, net income -35%, EPS $2.60 vs $3.83 prior year.
Preliminary results + Reg FD outlook signaling continued assignment/federal softness.
Q3'25 10-Q shows assignment weakness deepening; consulting mix offsets only partly.
Sources: SEC EDGAR (CIK 0000890564, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/25/2026, 3:08:24 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 11:08 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 8 open-market buys · 0 sales
| 2026-06-11 | HOLMAN JONATHAN S Director | Tax | 386.00 @ $20.20 | $7.80K |
| 2026-04-29 | Dyer Joseph Wendell Director | Buy | 1.11K @ $22.47 | $25.0K |
| 2026-04-28 | Cunningham Rose Chief Accounting Officer | Buy | 1.13K @ $22.27 | $25.1K |
| 2026-04-28 | Iyer Sadasivam President | Buy | 1.11K @ $22.67 | $25.2K |
| 2026-04-27 | Obermaier Patricia L Director | Buy | 2.50K @ $20.61 | $51.5K |
| 2026-04-27 | Lindstrom Carol Director | Buy | 240.00 @ $20.15 | $4.84K |
| 2026-04-27 | Lindstrom Carol Director | Buy | 7.00 @ $20.16 | $141.12 |
| 2026-04-27 | Callaghan Brian J. Director | Buy | 5.12K @ $20.27 | $104K |
| 2026-04-24 | Perry Marie EVP, Chief Financial Officer | Buy | 5.35K @ $18.70 | $100K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.